Collectively, these results indicate that RPAP2 expression is up‐regulated in HCC and that high RPAP2 expression is associated with advanced tumor grade and poor patient survival in HCC, implying a potential role for RPAP2 in promoting HCC development and progression. The gene discussed is RPAP2; the disease is hepatocellular carcinoma.